First experience of percutaneous radio-frequency ablation for atrial flutter and atrial fibrillation in a patient with HeartMate II left ventricular assist device
Philippe Maury(Hôpital Rangueil), Camille Dambrin(Centre Hospitalier Universitaire de Toulouse), Michel Galinier(Hôpital Rangueil), Charlotte Trouillet(Hôpital Rangueil), D. Bertrand, Olivier Lairez(Hôpital Rangueil), Clément Delmas(Université Toulouse III - Paul Sabatier), Jérôme Roncalli(Hôpital Rangueil), Marc Delay(Hôpital Rangueil), Alexandre Duparc(Hôpital Rangueil), Mark S. Slaughter(University of Louisville), Michelle Salvador(Hôpital Rangueil), Lydie Mathevet
Cited by 31
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711